Tenpoint Therapeutics Appoints Stephen S. Lane as CMO - Summary - MDSpire
Feature

Tenpoint Therapeutics Appoints Stephen S. Lane as CMO

ASCRS past-President joins ophthalmic pharmaceutical company

  • April 9, 2026

  • 2 min

Share

Tenpoint Therapeutics, Ltd. has appointed Stephen S. Lane, M.D., a prominent ophthalmologist with 40 years of experience, as Chief Medical Officer. Dr. Lane comes from Alcon, where he was CMO and Head of Medical Safety, and he has held various leadership roles in ophthalmology. His expertise in clinical practice and product development uniquely positions him to advance Tenpoint's innovative therapies for the aging eye. Dr. Lane is eager to contribute to significant improvements in patient outcomes and support eye care professionals.

Original Source(s)

Tenpoint Therapeutics Appoints Stephen S. Lane as CMO

  • April 9, 2026

Related Content

Built for Physicians, Designed for Precision

The Elara 900 expands on the existing gold-standard optics of Haag-Streit’s BQ 900, redefining the slit lamp experience for both physicians and patients

  • April 9, 2026

  • 7 min
Built for Physicians, Designed for Precision

The Elara 900 expands on the existing gold-standard optics of Haag-Streit’s BQ 900, redefining the slit lamp experience for both physicians and patients

  • April 9, 2026

  • 7 min
Could Red-Light Therapy Change Myopia Care? 

Across 28 trials, pediatric patients receiving therapy had less myopia progression over 12 months, though long-term risks remain under study.